Trial intelligence / Profile preview

Lidocaine for Painful Neuroma

NCT02300038Completed

Sponsor
Uppsala University
Start
Apr 2010
Primary completion
Aug 2013
Modality
Small Molecules
01

Overview

Randomised, double-blind trial of lidocaine in neuropathic pain (2 arms), sponsored by Uppsala University. Primary endpoint: Change in pain score measured from baseline until 60 min after injection. Started Apr 2010; status: completed.

02

Drugs

lidocaine
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT02300038.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02300038.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call